eGenesis Company
Xenotransplant
Investors
Founded Date:
2014
Total Funding:
$265.00
Investor Type:
Late Stage Venture
Employee Number:
11-50
Last Funding Type:
Series C
Investors Number:
27
Last Funding Date:
2021
Industry:
Risk Mitigation
Headquarters:
USA
Estimated Revenue:
$10M to $50M